Testing effectiveness (Phase 2)Ended earlyNCT01058642
What this trial is testing
Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
Who this might be right for
Postherpetic Neuralgia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 41